Lisinopril: Research, Dosing, and Where to Buy in 2026
A research-first profile for Lisinopril, aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.
Lisinopril is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers for Lisinopril, each linked to its source.
- 0 aggregated dosing-protocol mentions from source transcripts.
- 8 PubMed-indexed citations listed in the research table below.
- 0 vendor recommendations captured from named experts.
What is Lisinopril?
Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.
Lisinopril Dosing Protocols
The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.
No transcript-derived dosing mentions in current source set.
Where to Buy Lisinopril in 2026
No tracked vendor recommendations for Lisinopril yet. See our vendor directory.
Side Effects and Safety
Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.
User Reviews
User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.
Research Efficacy Snapshot
Published efficacy percentages cited in PubMed trials and named-expert reports about Lisinopril. Each line links to the original source.
- "Compared with recipients of low doses, those receiving high doses of lisinopril had an 8% lower risk of all-cause mortality (p = 0.128), a 12% lower risk of death or hospitalisation for any reason (p = 0.002) and 24% fewer hospitalisations for heart failure (p = 0.002)." · Simpson K et al, 2000 PubMed
- "In comparative and non-comparative clinical trials, 68.2 to 89.1% of elderly patients responded (diastolic pressure < or = 90 mm Hg) to > or = 8 weeks' lisinopril treatment." · Langtry H et al, 1997 PubMed
- "Elderly patients, however, among other subgroups, exhibited a strong reduction in risk of low ejection fraction after treatment (-25.5%)." · Langtry H et al, 1997 PubMed
- "Its bioavailability is approximately 25% and is not affected by food." · Chase S et al, 1989 PubMed
- "Approximately 29% of lisinopril is absorbed after oral administration." · Noble T et al, 1988 PubMed
Research and Studies
8 PubMed-indexed papers reference Lisinopril. Top 8 shown.
Legal Status
Lisinopril is presented here as a research compound. FDA approval status, scheduling, WADA status, and state-specific telehealth rules may apply. Always verify current regulatory status. Last verified: 2026-07-09.
Frequently Asked Questions
Is Lisinopril FDA-approved?
Lisinopril is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.
How much research has been published on Lisinopril?
8 PubMed-indexed paper(s) reference Lisinopril in our current research feed. See the Research and Studies section above for citations.